INBS · NASDAQ
Intelligent Bio Solutions (INBS) Stock Price & Fundamentals
Intelligent Bio Solutions (INBS) closed at $459.94 on Oct 9, 2026, up 1.10% from the previous close of $454.92.
Share price, past year
1Y +12.89%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $459.94 |
| Sep 30, 2026 | $455.72 |
| Aug 31, 2026 | $424.64 |
| Jul 31, 2026 | $418.25 |
| Jun 30, 2026 | $446.42 |
| May 29, 2026 | $447.47 |
| Apr 30, 2026 | $474.94 |
| Mar 31, 2026 | $474.93 |
| Feb 27, 2026 | $462.35 |
| Jan 30, 2026 | $448.08 |
| Dec 31, 2025 | $437.52 |
| Nov 28, 2025 | $420.51 |
| Oct 31, 2025 | $411.83 |
Key statistics
- Market cap
- $1.34B
- P/E (TTM)
- —
- EPS (TTM)
- −$8.44
- Revenue (TTM)
- $4.22M
- Net income (TTM)
- −$12.43M
- Shares outstanding
- 2.9M
- Dividend yield
- —
- 52-week range
- $407.43 – $484.28
Intelligent Bio Solutions's market cap is $1.34B, based on a share price of $459.94 and 2.9M shares outstanding as of Jun 30, 2026.
Financials
Intelligent Bio Solutions reported revenue of $4.22M for fiscal 2026, up 38.09% from fiscal 2025.
Intelligent Bio Solutions reported a net loss of $12.43M in fiscal 2026.
Fiscal 2026 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jun 30, 2026 | $4.22M | +38.1% | −$12.43M | −294.9% | −$8.44 | −$12.05M |
| FY2025ended Jun 30, 2025 | $3.05M | −1.9% | −$10.57M | −346.2% | −$20.04 | −$9.91M |
| FY2024ended Jun 30, 2024 | $3.11M | +147.6% | −$10.16M | −326.4% | −$6.38 | −$9.79M |
| FY2023ended Jun 30, 2023 | $1.26M | +187.5% | −$10.63M | −845.9% | −$127.00 | — |
| FY2022ended Jun 30, 2022 | $437.15K | −77.9% | −$8.31M | −1,900.1% | −$11.33 | — |
| FY2021ended Jun 30, 2021 | $1.98M | +949.3% | −$7.04M | −355.3% | −$0.68 | — |
| FY2020ended Jun 30, 2020 | $188.74K | — | −$3.16M | −1,676.2% | −$0.37 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2026ended Jun 30, 2026 | $1.15M | −$3.91M | −$3.47 |
| Q3 FY2026ended Mar 31, 2026 | $1.06M | −$2.86M | −$1.80 |
| Q2 FY2026ended Dec 31, 2025 | $896.77K | −$2.68M | −$2.82 |
| Q1 FY2026ended Sep 30, 2025 | $1.11M | −$2.98M | −$0.35 |
| Q4 FY2025ended Jun 30, 2025 | $410.85K | −$3.09M | −$9.97 |
| Q3 FY2025ended Mar 31, 2025 | $902.14K | −$2.54M | −$4.41 |
| Q2 FY2025ended Dec 31, 2024 | $741.13K | −$2.25M | −$4.96 |
| Q1 FY2025ended Sep 30, 2024 | $998.42K | −$2.69M | −$0.70 |
Company profile
- Name
- Intelligent Bio Solutions Inc.
- Ticker
- INBS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 135 W 41st St,, Floor 5, New York, NY 10036
- Incorporated in
- DE
- Fiscal year ends
- June
- SEC CIK
- 0001725430
Recent SEC filings
- Sep 11, 2026
- Sep 9, 2026
- Sep 2, 2026
- Sep 1, 2026
- Aug 28, 2026
- Aug 19, 2026
- Aug 19, 2026
- Aug 11, 2026
Frequently asked questions
What is Intelligent Bio Solutions's stock price?
Intelligent Bio Solutions (INBS) closed at $459.94 on Oct 9, 2026, up 1.10% from the previous close of $454.92.
What is Intelligent Bio Solutions's market cap?
Intelligent Bio Solutions's market cap is $1.34B, based on a share price of $459.94 and 2.9M shares outstanding as of Jun 30, 2026.
How much revenue does Intelligent Bio Solutions make?
Intelligent Bio Solutions reported revenue of $4.22M for fiscal 2026, up 38.09% from fiscal 2025.
Does Intelligent Bio Solutions pay a dividend?
Intelligent Bio Solutions's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Intelligent Bio Solutions Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures